Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections - Wikidata - awgldk - TriplyDB

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

http://www.wikidata.org/entity/Q24594815

about

Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants Bacterial meningitis in infants Pediatric anthrax clinical management Importance of Drug Pharmacokinetics at the Site of Action Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology Dosing in neonates: special considerations in physiology and trial design.Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants Adverse consequences of neonatal antibiotic exposure Short versus long infusion of meropenem in very-low-birth-weight neonates New antibiotic dosing in infants.Pharmacokinetic studies in infants using minimal-risk study designs How to optimize the evaluation and use of antibiotics in neonates White paper: recommendations on the conduct of superiority and organism-specific clinical trials of antibacterial agents for the treatment of infections caused by drug-resistant bacterial pathogens Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience.Developmental pharmacokinetics of piperacillin and tazobactam using plasma and dried blood spots from infants.Clinical pharmacology of carbapenems in neonates.Dosage individualization in children: integration of pharmacometrics in clinical practice.Ethics of drug studies in the newborn.Dosing antibiotics in neonates: review of the pharmacokinetic data.Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period.The amikacin research program: a stepwise approach to validate dosing regimens in neonates.Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.Off-label use of antimicrobials in neonates in a tertiary children's hospital.Therapeutic Drug Monitoring of Meropenem in Neonate with Necrotizing Enterocolitis: A Challenge.Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates.Antimicrobial dosing in neonates.Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates.

P2860

Q24616863-50583BA8-E56A-409B-9B77-FCC13B356B67 Q24626231-7501B8CB-558A-48B4-9AB0-389E425DB5DD Q28082173-7D38845D-C1EB-4FDE-86E4-9FCBA7EC1324 Q28397091-20B968FD-8FFF-43C0-8A25-710F616D14C0 Q33648045-661335BB-DEFB-4C6A-AB29-552B6B546FB5 Q33797863-2EADCFC3-FEEC-44D8-9F57-B24B34BA9099 Q33827819-51AE00D2-1793-4A5E-90E0-9FDFD4AAF2F0 Q34716879-3B6C0ACA-336E-44A1-AF10-E9F127F7FCFA Q35859870-D168B53F-93A0-4FEB-B1FE-3E3BB852E63E Q35867330-50350323-F225-426D-A18B-F6F01CECFB4B Q35926313-4AF57B4E-2D1B-4383-B691-A161A90F785F Q36172523-90DDF164-B9E1-43C8-853D-8E47C0C51F1D Q36438111-EDC4E413-788B-4FBE-ADC4-5E20AB254161 Q36438116-3EFFCBCE-0374-4C4F-A06A-0720C7B9C793 Q36452369-60E28257-5B14-4985-BFCE-7E1F73E18DF4 Q36854025-5330B064-082A-4F88-9571-92E61D62B339 Q37203671-F94D8B31-7DA6-4E78-82A7-ADFF541B1025 Q37713019-EF3EF802-D4F4-4EDF-9E2A-162B275E9374 Q38148807-108457DD-3E52-41BB-8CBF-3F1ED94157E1 Q38240055-51A4143D-7F51-4075-A9D7-AFC790A3DB2E Q38263730-52DB8B57-26F9-4EF1-AB7F-052D19BEFC53 Q38649419-5509F95D-7FEE-4ABD-BE5D-34D73D16B1C5 Q38657914-FA7374A3-406F-461C-AB0D-12EC3DE43D52 Q38696468-BC510167-4952-4B3C-BC3A-9BC38AEEE21E Q38714060-24B60391-CAAE-41BF-8DBB-B7AAB5368ACB Q38821699-9F5D348C-12F0-45C8-8AE1-D41E20B0A926 Q38935160-EA77D5AE-A2F6-48E4-A6A4-A73D12E31905 Q39013368-F7D71700-3650-4634-ADC9-C0823C63AFDF Q39322437-7C8430D9-D455-444D-AF8B-3A4CF77C7894 Q39492202-D3CBAE54-1B74-41DE-9870-9D5C7947312E Q40380011-B6C61FBD-946A-4828-B190-39F2616C6847 Q47428031-5F64BCC7-8A5E-481C-895C-9A01145326EE

P2860

Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections

http://www.wikidata.org/entity/Q24594815

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Population pharmacokinetics of ...... ted intra-abdominal infections

@ast

Population pharmacokinetics of ...... ted intra-abdominal infections

@en

Population pharmacokinetics of ...... ted intra-abdominal infections

@nl

type

label

Population pharmacokinetics of ...... ted intra-abdominal infections

@ast

Population pharmacokinetics of ...... ted intra-abdominal infections

@en

Population pharmacokinetics of ...... ted intra-abdominal infections

@nl

prefLabel

Population pharmacokinetics of ...... ted intra-abdominal infections

@ast

Population pharmacokinetics of ...... ted intra-abdominal infections

@en

Population pharmacokinetics of ...... ted intra-abdominal infections

@nl

P1433

Q24594815-AA9CAAA9-331C-4A84-AA22-80BA371B19E4

P1476

Q24594815-3ACBDC89-5E44-491D-BE77-51BBC8036E0B

P2093

Q24594815-024FEE85-B20D-40B8-9A42-36C091E66A6C

Q24594815-0948F2E4-53E0-4CB9-9C55-79A85237B351

Q24594815-120FA930-9789-4EA5-8C61-F45E53CE749F

Q24594815-19B7E6D3-109E-4EBC-ABA3-C06910B62840

Q24594815-2478F599-FF27-43DF-9A79-EA0F3C568E59

Q24594815-25E44B58-F12A-4D83-B89B-46B6CE08C3E6

Q24594815-28EE8C64-87CF-4AC1-BA63-0E194B45346C

Q24594815-3F615E8B-6CDC-4695-B4A0-AA8E9DF4FE36

Q24594815-46F14562-33AC-4D1F-8462-779E2AF7A5FF

Q24594815-4A6C3F60-DC34-43FF-84FB-821C54914177

P2860

Q24594815-0058F334-C48B-4238-A06B-8474B03F14D2

Q24594815-025AA91C-726F-4020-BF73-06217E660C95

Q24594815-239EF69A-8466-41F5-A19D-DB6F21FE015F

Q24594815-334392ED-3DCC-4C3E-A621-5B7C1031A754

Q24594815-3BFB3DFB-3DEF-4E76-8DF2-E08DD734E329

Q24594815-44425BFE-8BBA-44D5-85BA-89B770D63406

Q24594815-4DBC6777-4D84-4806-972C-C1D7ED5BDD42

Q24594815-A1D50F27-9FBF-47F3-B81D-7628AED67FED

Q24594815-A5E2C8D7-8DB4-4A05-8D17-B68138828743

Q24594815-E458CD1D-6E31-4E2D-93D9-D7DDA9D16874

P304

Q24594815-B55A57D8-7F8B-487E-A8B1-8DFCBDFB7E4F

P31

Q24594815-34FA61F0-FFCD-45D9-9969-BC581C5D49E6

P3181

Q24594815-B282AF7B-0EB4-4D83-A470-61EF8FBE8F15

P356

Q24594815-8F21E5A5-F9AC-4121-A253-FC6D6C269431

P407

Q24594815-85043AE9-BDAA-4E3C-BA80-F7C560C8B7C7

P433

Q24594815-BFE959A0-3337-4269-99AA-92071BE66181

P478

Q24594815-3FDC1A82-2501-4867-9022-CDA0C6286683

P577

Q24594815-33F9B281-F892-4824-93B7-5CD9976F9B98

P698

Q24594815-4C38A016-A63E-4531-8FBD-8783CE1D6E79

P921

Q24594815-3C4AC936-35FB-4F36-8C08-896C890C42D1

Q24594815-CD60E08E-90D1-4B2D-A861-3840D72FF12A

P932

Q24594815-A7A6934C-24BC-4EDE-AAC7-967E80DA5E8A

P3181

P356

INF.0B013E31822E8B0B

P1433

Pediatric Infectious Disease Journal

P1476

Population pharmacokinetics of ...... ted intra-abdominal infections

@en

P2093

Anand Kantak

http://www.w3.org/2001/XMLSchema#string

Antonio Arrieta

http://www.w3.org/2001/XMLSchema#string

Beverly S Brozanski

http://www.w3.org/2001/XMLSchema#string

Brenda Poindexter

http://www.w3.org/2001/XMLSchema#string

Daniel K Benjamin

http://www.w3.org/2001/XMLSchema#string

David Burchfield

http://www.w3.org/2001/XMLSchema#string

Edmund V Capparelli

http://www.w3.org/2001/XMLSchema#string

Gloria Valencia

http://www.w3.org/2001/XMLSchema#string

Gregory L Kearns

http://www.w3.org/2001/XMLSchema#string

Janice E Sullivan

http://www.w3.org/2001/XMLSchema#string

P2860

Population pharmacokinetics of cefepime in the neonate.

Meropenem pharmacokinetics in the newborn.

Pharmacokinetics of meropenem and its metabolite in young and elderly healthy men

Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation.

A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.

Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994.

Pharmacokinetics of meropenem in preterm neonates.

Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994.

Human renal function maturation: a quantitative description using weight and postmenstrual age.

Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate.

P304

844-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3496285

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/INF.0B013E31822E8B0B

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21829139

http://www.w3.org/2001/XMLSchema#string

P921

pharmacokinetics

cerebrospinal fluid

P932

3173561

http://www.w3.org/2001/XMLSchema#string